<DOC>
	<DOC>NCT01190072</DOC>
	<brief_summary>The purpose of the study is to follow the management of blood lipids in patients with planned percutaneous coronary intervention (widening of coronary vessels) in a period from 6 to 10 weeks after the intervention.</brief_summary>
	<brief_title>Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Male or nonpregnant female Coronary patient hospitalised for elective PCI Hypercholesterolaemia defined as LDLC â‰¥ 2 mmol/L Any chronic inflammatory condition Chronic antiinflammatory pharmacotherapy (except lowdose ASA)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Blood lipids</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>lipid lowering treatment</keyword>
</DOC>